V. Blatt

<i>MGMT</i> Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Alba A. Brandes, Enrico Franceschi, Alicia Tosoni et al. · Journal of Clinical Oncology · 2008 · 831 citations · Full text

Medicine, Oncology, Radiology +17

Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study

Alba A. Brandes, Alicia Tosoni, Giovanna Cavallo et al. · Journal of Clinical Oncology · 2006 · 194 citations

Medicine, Oncology, Radiation Oncology +17

Long‐term results of a prospective study on the treatment of medulloblastoma in adults

Alba A. Brandes, Enrico Franceschi, Alicia Tosoni et al. · Cancer · 2007 · 147 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

A. Tosoni, Enrico Franceschi, Mario Ermani et al. · Journal of Neuro-Oncology · 2008 · 78 citations

Medicine, Oncology, Pharmacotherapy +13

Is protracted low-dose temozolomide feasible in glioma patients?

A. Tosoni, Giovanni Cavallo, Mario Ermani et al. · Neurology · 2006 · 37 citations

Medicine, Oncology, Pharmacology +17